Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.

Authors

Christoph Wanner
Silvio Inzucchi
John M. Lachin, George Washington UniversityFollow
Maximilian von Eynatten
Michaela Mattheus
Odd Erik Johansen
Hans J. Woerle
Uli C. Broedl
Bernard Zinman

Document Type

Journal Article

Publication Date

7-2016

Journal

New England Journal of Medicine

Volume

375

Issue

4

Inclusive Pages

323-334

DOI

10.1056/NEJMoa1515920

APA Citation

Wanner, C., Inzucchi, S., Lachin, J. M., von Eynatten, M., Mattheus, M., Johansen, O., Woerle, H. J., Broedl, U. C., & Zinman, B. (2016). Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.. New England Journal of Medicine, 375 (4). http://dx.doi.org/10.1056/NEJMoa1515920

Peer Reviewed

1